Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Cardiac Fibrosis in STEMI
NCT06426537Phase 1Completed
- Sponsor
- Brawijaya University
- Start
- Oct 2022
- Primary completion
- Mar 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of colchicine in ST elevation myocardial infarction (STEMI) (4 arms), sponsored by Brawijaya University. Primary endpoint: Left Ventricular End-Diastolic Volume at 1 month. Started Oct 2022; status: completed.
02
Drugs
colchicine
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06426537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06426537.